Abstract:YAP1 is a key mediator of the Hippo pathway capable of exerting a profound effect on organ size as well as tumorigenesis. Alternative mRNA splicing of human YAP1 results in at least 8 protein isoforms that differ within the 2nd WW motif and the transcriptional activation domain. Methods: To investigate the isoform-specific differences in their mRNA expression, transcriptional activity and tumor-promoting function, we cloned cDNA encoding all of the eight YAP1 protein isoforms. Then, we examined their mRNA expression, subcellular localization, transcriptional regulation properties, interactions with key regulatory partners, and protein stability in response to changes in cell density, as well as their effects on pancreatic cancer cell malignancy both in vitro and in vivo. Results: Multiple YAP1 mRNA isoforms are expressed in commonly used pancreatic cancer lines as well as human pancreatic cancer PDX lines. Based on the analysis of heterologous reporter and endogenous target genes, all YAP1 isoforms are capable of activating transcription, albeit to a different extent. Importantly, we unveiled a marked discrepancy between the mRNA and protein expression levels of the YAP1-1 and YAP1-2 isoforms. We further discovered that the YAP1-2 isoform, which contains two tandem WW motifs, is less stable at the protein level, particularly at high cell densities. Mechanistically, we found that the presence of the 2nd WW motif in YAP1-2 facilitates the de novo formation of the YAP1-2/AMOT/LATS1 complex and contributes to a stronger binding of YAP1-2 to LATS1 and subsequently increased YAP1-2 ubiquitination and degradation by beta-TRCP. Conclusion: Our data reveals a potent effect of YAP1-1 on pancreatic cancer malignancy in vitro and in vivo and provides novel mechanistic insight into isoform-specific and cell density-dependent regulation of YAP1 stability, as well as its impact on cancer malignancy.

YAP signaling is involved in WDR1-regulated proliferation and migration of non-small-cell lung cancer cells

Ascl2 Activation by YAP1/KLF5 Ensures the Self-Renewability of Colon Cancer Progenitor Cells

WDR1 Promotes Cell Growth and Migration and Contributes to Malignant Phenotypes of Non-small Cell Lung Cancer Through ADF/cofilin-mediated Actin Dynamics

Both Tead-Binding and Ww Domains Are Required for the Growth Stimulation and Oncogenic Transformation Activity of Yes-Associated Protein

Inactivation of Yap Oncoprotein by the Hippo Pathway is Involved in Cell Contact Inhibition and Tissue Growth Control

A Coordinated Phosphorylation By Lats And Ck1 Regulates Yap Stability Through Scf Beta-Trcp

PRDM 4 Mediates YAP ‐induced Cell Invasion by Activating Leukocyte‐specific Integrin Β2 Expression

Integration of Mechanical and Chemical Signals by YAP and TAZ Transcription Coactivators.

YAP Promotes Migration and Invasion of Human Glioma Cells

Overexpression of Yes-Associated Protein Contributes to Progression and Poor Prognosis of Non-Small-cell Lung Cancer.

YAP1 activation promotes epithelial-mesenchymal transition and cell survival of renal cell carcinoma cells under shear stress

Overexpression Of Yes-Associated Protein Contributes To Apoptosis Of Lung Cancer

NDR1 Functions As Tumor Suppressor in Glioblastoma by Phosphoralation of YAP

YAP engages RIF1 to dampen replication stress in squamous cell carcinoma.

The WW domains dictate isoform-specific regulation of YAP1 stability and pancreatic cancer cell malignancy

Yes-associated protein regulates the growth of human non-small cell lung cancer in response to matrix stiffness.

YAP mediates resistance to EGF-induced apoptosis in EGFR-mutated non-small cell lung cancer cells

The Hippo/YAP1 Pathway Interacts with FGFR1 Signaling to Maintain Stemness in Lung Cancer.

Role of YAP Signaling in Regulation of Programmed Cell Death and Drug Resistance in Cancer

YAP controls cell migration and invasion through a Rho-GTPase switch

Targeting YAP1/LINC00152/FSCN1 Signaling Axis Prevents the Progression of Colorectal Cancer